Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasm Metastasis 1Kidney Neoplasms 1Kidney Failure, Chronic 1Carcinoma, Renal Cell 1

Interventions

Magnetic Resonance Spectroscopy 46Specimen Handling 42Nivolumab 30pembrolizumab 29enzalutamide 28Gemcitabine 24Docetaxel 24apalutamide 20Prednisone 20Biopsy 19cabozantinib 17Abiraterone Acetate 17enfortumab vedotin 15Androgen Antagonists 15abiraterone 14Cisplatin 14darolutamide 13Radiotherapy 13Pluvicto 12Ipilimumab 12Mitomycin 11olaparib 10atezolizumab 10X-Rays 10erdafitinib 9cabazitaxel 9Radiation 9Carboplatin 9belzutifan 8Standard of Care 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
orellanine × Genitourinary × 30 days × Clear all
NCT05287945 2026-05-22

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Oncorena AB

Phase 1/2 Recruiting
75 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Failure, Chronic, Kidney Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡